BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pérez-carbonell L. Treatment of Excessive Daytime Sleepiness in Patients with Narcolepsy. Curr Treat Options Neurol 2019;21. [DOI: 10.1007/s11940-019-0595-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Gill I, Sheils A, Reade E, O’malley S, Carey A, Muldoon M, Wagle A, Crowe C, Lynch B. Narcolepsy in children and young people in Ireland: 2006–2017. European Journal of Paediatric Neurology 2020;28:52-7. [DOI: 10.1016/j.ejpn.2020.07.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Wang J, Li X, Yang S, Wang T, Xu Z, Xu J, Gao H, Chen G. Pitolisant versus placebo for excessive daytime sleepiness in narcolepsy and obstructive sleep apnea: A meta-analysis from randomized controlled trials. Pharmacol Res 2021;167:105522. [PMID: 33667687 DOI: 10.1016/j.phrs.2021.105522] [Reference Citation Analysis]
3 Subedi R, Singh R, Thakur RK, K C B, Jha D, Ray BK. Efficacy and safety of solriamfetol for excessive daytime sleepiness in narcolepsy and obstructive sleep apnea: a systematic review and meta-analysis of clinical trials. Sleep Med 2020;75:510-21. [PMID: 33032062 DOI: 10.1016/j.sleep.2020.09.019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
4 Yu YA. Pediatric Sleep Medicine Cases. Curr Sleep Med Rep 2022;:1-12. [PMID: 35345531 DOI: 10.1007/s40675-022-00223-8] [Reference Citation Analysis]